BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38322103)

  • 1. Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumatica.
    Manzo C; Castagna A; Veronese N; Isetta M
    Reumatologia; 2023; 61(6):432-438. PubMed ID: 38322103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica.
    De Miguel E; Macchioni P; Conticini E; Campochiaro C; Karalilova R; Monti S; Ponte C; Klinowski G; Monjo-Henry I; Falsetti P; Batalov Z; Tomelleri A; Hocevar A
    Rheumatology (Oxford); 2024 Jan; 63(1):158-164. PubMed ID: 37129541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica - a prospective cohort study.
    Burg LC; Karakostas P; Behning C; Brossart P; Kermani TA; Schäfer VS
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X221149963. PubMed ID: 36777696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intima-media thickness cut-off values depicting "halo sign" and potential confounder analysis for the best diagnosis of large vessel giant cell arteritis by ultrasonography.
    Milchert M; Fliciński J; Brzosko M
    Front Med (Lausanne); 2022; 9():1055524. PubMed ID: 36582293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing vasculitis with ultrasound: findings and pitfalls.
    Schmidt WA; Schäfer VS
    Ther Adv Musculoskelet Dis; 2024; 16():1759720X241251742. PubMed ID: 38846756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data.
    Hemmig AK; Gozzoli D; Werlen L; Ewald H; Aschwanden M; Blockmans D; Brouwer E; Buchanan RRC; Camellino D; Campochiaro C; Cimmino MA; Corominas H; Gloy V; Henckaerts L; Kyburz D; Moya-Alvarado P; Owen CE; Stegert M; Tomelleri A; van Sleen Y; Yamashita H; Imfeld S; Berger CT; Hemkens LG; Daikeler T
    Semin Arthritis Rheum; 2022 Aug; 55():152017. PubMed ID: 35537222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
    De Miguel E; Karalilova R; Macchioni P; Ponte C; Conticini E; Cowley S; Tomelleri A; Monti S; Monjo I; Batalov Z; Klinowski G; Falsetti P; Kane DJ; Campochiaro C; Hočevar A
    Ann Rheum Dis; 2024 Feb; 83(3):335-341. PubMed ID: 37932008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients.
    Ramon A; Greigert H; Ornetti P; Maillefert JF; Bonnotte B; Samson M
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
    Salvarani C; Padoan R; Iorio L; Tomelleri A; Terrier B; Muratore F; Dasgupta B
    Autoimmun Rev; 2024 Jan; 23(1):103415. PubMed ID: 37625672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior polymyalgia rheumatica is associated with sonographic vasculitic changes in newly diagnosed patients with giant cell arteritis.
    Hemmig AK; Aschwanden M; Berger CT; Kyburz D; Mensch N; Staub D; Stegert M; Imfeld S; Daikeler T
    Rheumatology (Oxford); 2024 May; 63(6):1523-1527. PubMed ID: 37647653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center Study.
    Manzo C; Castagna A; Isetta M
    Life (Basel); 2023 May; 13(6):. PubMed ID: 37374068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
    Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
    Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update.
    Nesher G; Breuer GS
    Rambam Maimonides Med J; 2016 Oct; 7(4):. PubMed ID: 27824543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J; Warrington KJ
    Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.
    Dejaco C; Duftner C; Buttgereit F; Matteson EL; Dasgupta B
    Rheumatology (Oxford); 2017 Apr; 56(4):506-515. PubMed ID: 27481272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
    Barde F; Ascione S; Pacoureau L; Macdonald C; Salliot C; Boutron-Ruault MC; Seror R; Nguyen Y
    Semin Arthritis Rheum; 2024 Feb; 64():152298. PubMed ID: 38000317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
    J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyalgia rheumatica: A case series from Colombia and analysis of Latin America.
    Toro-Gutiérrez CE; Cañas CA; Mantilla RD; Beltrán S; Pastrana-Gonzalez V; Vecino MJ; Rodriguez-Jimenez M; Rojas M
    J Transl Autoimmun; 2021; 4():100115. PubMed ID: 34485886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.